Evotec SE (EVO) Net Cash Flow (2009 - 2026)
Evotec SE's (EVO) quarterly Net Cash Flow came in at -$41.5 million in Q1 2026, down 119.31% year-over-year from $214.9 million in Q1 2025, and down 26.99% quarter-over-quarter from -$32.7 million in Q4 2025.
Analysis
Evotec SE (EVO) Net Cash Flow (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Net Cash Flow across 9 years of filings, most recently posting -$41.5 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 119.31% year-over-year to -$41.5 million; the TTM figure through Mar 2026 stood at -$187.2 million (down 18.03% YoY), while the FY2025 annual figure was $141.0 million, up 160.76% from the prior year.
- Net Cash Flow came in at -$41.5 million for Q1 2026 at Evotec SE, down from -$32.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $199.4 million in Q3 2022 to a low of -$460.0 million in Q4 2022.
- Average Net Cash Flow over 5 years is -$41.4 million, with a median of -$15.2 million recorded in 2025.
- The largest YoY upside for Net Cash Flow was 370.55% in 2024 against a maximum downside of 1082.02% in 2024.
- Over 5 years, Net Cash Flow stood at -$460.0 million in 2022, then jumped by 103.05% to $14.0 million in 2023, then surged by 370.55% to $66.1 million in 2024, then tumbled by 149.46% to -$32.7 million in 2025, then decreased by 26.99% to -$41.5 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$41.5 million in Q1 2026, -$32.7 million in Q4 2025, and -$101.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -37.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -150.21 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 164.82 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 43.16 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 21.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.70 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -514,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.71 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -41.49 Mn |
| Dec 31, 2025 | -32.67 Mn |
| Sep 30, 2025 | -101.63 Mn |
| Jun 30, 2025 | -11.41 Mn |
| Mar 31, 2025 | -18.92 Mn |
| Dec 31, 2024 | 66.05 Mn |
| Sep 30, 2024 | 10.43 Mn |
| Jun 30, 2024 | -216.18 Mn |
| Mar 31, 2024 | -92.29 Mn |
| Dec 31, 2023 | 14.04 Mn |
| Jun 30, 2023 | 27.16 Mn |
| Mar 31, 2023 | 9.40 Mn |
| Dec 31, 2022 | -460.00 Mn |
| Sep 30, 2022 | 199.44 Mn |
| Jun 30, 2022 | 27.04 Mn |
| Mar 31, 2022 | -41.97 Mn |
| Dec 31, 2021 | 69.81 Mn |
| Sep 30, 2021 | 77.56 Mn |
| Jun 30, 2021 | 159.12 Mn |
| Mar 31, 2021 | 21.58 Mn |